Twin Tree Management
MRNA icon

Twin Tree Management’s Moderna MRNA Stock Holding History

Twin Tree Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,000
Closed -$469K – 1710
2025
Q2 		$469K Sell
17,000
-13,600
-44% -$358K ﹤0.01% 1448
2025
Q1 		$868K Sell
30,600
-42,900
-58% -$1.52M ﹤0.01% 1281
2024
Q4 		$3.06M Sell
73,500
-12,300
-14% -$588K 0.01% 1060
2024
Q3 		$5.73M Sell
85,800
-178,400
-68% -$16.4M 0.01% 857
2024
Q2 		$31.4M Buy
264,200
+117,200
+80% +$14.8M 0.07% 244
2024
Q1 		$15.7M Buy
+147,000
New +$14.8M 0.03% 483
2023
Q4 		– Sell
-214,100
Closed -$22.1M – 1516
2023
Q3 		$22.1M Sell
214,100
-516,000
-71% -$57.6M 0.05% 331
2023
Q2 		$88.7M Sell
730,100
-95,000
-12% -$12.7M 0.14% 117
2023
Q1 		$127M Buy
825,100
+426,600
+107% +$70.4M 0.24% 57
2022
Q4 		$71.6M Buy
398,500
+136,000
+52% +$22.2M 0.15% 115
2022
Q3 		$31M Sell
262,500
-106,400
-29% -$16.1M 0.06% 271
2022
Q2 		$52.7M Hold
368,900
– – 0.08% 169
2022
Q1 		$63.5M Buy
368,900
+359,800
+3,954% +$60.6M 0.1% 146
2021
Q4 		$2.31M Sell
9,100
-93,500
-91% -$27.3M ﹤0.01% 1071
2021
Q3 		$39.5M Sell
102,600
-229,600
-69% -$84.7M 0.09% 219
2021
Q2 		$78.1M Buy
332,200
+75,200
+29% +$13.4M 0.21% 94
2021
Q1 		$33.7M Buy
+257,000
New +$37.2M 0.13% 169
2020
Q4 		– Sell
-2,800
Closed -$198K – 1414
2020
Q3 		$198K Sell
2,800
-12,000
-81% -$837K ﹤0.01% 1030
2020
Q2 		$950K Buy
14,800
+13,100
+771% +$717K ﹤0.01% 1066
2020
Q1 		$51K Buy
+1,700
New +$39.1K ﹤0.01% 1155

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Twin Tree Management's MRNA Position: Q1 2026 in Review

Twin Tree Management increased its Moderna (MRNA) stake by 84% in Q1 2026, buying an estimated $2.66M and bringing the position to 125,203 shares worth $6.36M. The position accounts for 0.13% of the portfolio, ranked #166.

Twin Tree Management first reported a position in MRNA in Q1 2020 and has held it in 20 quarters since. The position peaked at $47.5M in Q4 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Twin Tree Management held 125,203 shares of Moderna worth $6.36M as of Q1 2026.
  • Twin Tree Management bought 57,026 Moderna shares in Q1 2026, an estimated $2.66M.
  • Moderna made up 0.13% of Twin Tree Management's portfolio in Q1 2026, its #166 holding.
  • Twin Tree Management first reported a position in Moderna in Q1 2020 and has held it in 20 quarters since.
  • Twin Tree Management's Moderna position peaked at $47.5M in Q4 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.